Algoritma Tes HIV
Algoritma Tes HIV
HIV
Agnes R. Indrati
Divisi Imunoserologi
Dept. Patologi Klinik
FK Universitas Padjadjaran/ RS Hasan Sadikin
Bandung
HIV in Indonesia
HIV AIDS Situation in Indonesia
700000
90-90-90 Target cascade
600000
500000
400000
300000 39.9%
200000
32.2%
100000
?
0
Estimated Knew their On treatment Virally
number of HIV status suppresed ?
PLHIV
ART Oportunistic
Initiation Infection
HIV serological assays
Window Period based on tests method
Performance Characteristic of HIV tests
Performance Characteristic of HIV tests
HIV Test Algorithm in Indonesia
Retesting
WHO recommendations retesting is warranted for the following populations:
1. Individuals testing HIV-negative who:
• have ongoing risk for HIV infection
• pregnant, in high HIV prevalence settings; HIV-negative in the first trimester
2. Individuals whose HIV status is inconclusive
• return in 14 days for additional testing to confirm their diagnosis
3. Individuals diagnosed HIV-positive
• should be retested to verify their HIV
• Retesting is not recommended for individuals on ART
POCT
Flowcy tometry
• need to scale up
VL testing • the most effective method to evaluate the response of ART
benefit limitation
the cost per test is similar to
relatively easy to use most other commercial VL
assays
requires a relatively
already being used for TB
sophisticated laboratory
diagnosis
setting
Kulkarni et al. BMC Infect Deis2017; 17: 506 Brook G. BMJ. Sex Transm Infect. 2018
Early Infant Diagnosis
• The WHO & UNICEF recommended virological testing for infant HIV
diagnosis (< 18 m of age)
• Quantitative viral RNA or qualitative proviral DNA
• Minimum sensitivity of 95% (preferably 98%) & specificity of 99%.
• Virological testing for HIV-exposed infants at 4-6 weeks of age or at the
earliest opportunity thereafter
Early Infant Diagnosis
• The most widely-used test for EID is a DNA PCR molecular test, which is
also performed on sophisticated laboratory-based instruments.
• HIV-1 DNA test detects HIV proviral DNA
• Alternatively the RNA PCR quantitative tests/ viral load
Dried blood spot
HIV test algorithm in infant/ children <18
months
Dried Blood Spot
• Greater stability than fresh whole blood / plasma
• Simplifies samples transport
• Cost effective.
expand testing access into peri-urban & rural settings
Advantages
• easily obtained, stored, & training required is less intensive
• more stable over longer periods
• DBS are more easily transported
Disadvantages
• reduced sensitivity of viral RNA amplification
• in low viral loads, genotyping results is not accurate
• challenges surrounding the pre-extraction and analytical stages need
to be resolved
VL Comparison from Plasma & DBS
in Asia & Africa